Stock ALLO ALLOGENE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Allogene Therapeutics, Inc.

Equities

ALLO

US0197701065

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/05/2024 am IST 		5-day change 1st Jan Change
2.92 USD +5.80% Intraday chart for Allogene Therapeutics, Inc. -3.95% -9.03%
26/04 Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development MT
26/04 Allogene Therapeutics Receives Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ALLOGENE THERAPEUTICS, INC.
Bio Therapeutic Drugs
+5.80%-3.95%-9.03%-47.20%-90.09% 471M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ALLO Stock
  4. Charts Allogene Therapeutics, Inc.
  5. Comparison Chart